Close

content

Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API

Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, an active pharmaceutical ingredient...

Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies

Orgenesis Inc., a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), announces that it...

cGMP Compliance: Rules to safeguarding patient well-being

cGMP, which means ‘current Good Manufacturing Practice’, is a key component of the pharmaceutical industry and outlines the requirements necessary for ensuring the quality...

Almost one third of life science companies set to begin quantum computing evaluation this year

New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third (31 percent) of life science...

Byondis Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL in Early-Stage Breast Cancer

Byondis B.V. announced that Quantum Leap Healthcare Collaborative selected the company’s investigational antibody-drug conjugate (ADC) SYD985 (trastuzumab duocarmazine) for a new investigational treatment arm...

Tim Consult launches air cargo benchmarking initiative for pharma industry

Air freight experts at Tim Consult have launched the special Market Intelligence Initiative “MII Pharma Air Cargo”, aimed at providing pharmaceutical industry specialists with...

Arctoris contributes its capabilities and expertise to the fight against COVID-19

Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the world desperately search for novel...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read